Doxercalciferol

From WikiProjectMed
Jump to navigation Jump to search
Doxercalciferol
Names
IUPAC name
(1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3-diol
Other names
1-Hydroxyergocalciferol; 1-Hydroxyvitamin D2; 1α-Hydroxyergocalciferol; 1α-Hydroxyvitamin D2; Hectorol; TSA 840
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
DrugBank
UNII
  • InChI=1S/C28H44O2/c1-18(2)19(3)9-10-20(4)25-13-14-26-22(8-7-15-28(25,26)6)11-12-23-16-24(29)17-27(30)21(23)5/h9-12,18-20,24-27,29-30H,5,7-8,13-17H2,1-4,6H3/b10-9+,22-11+,23-12-/t19-,20+,24+,25+,26-,27-,28+/m0/s1 checkY
    Key: HKXBNHCUPKIYDM-CGMHZMFXSA-N checkY
  • InChI=1/C28H44O2/c1-18(2)19(3)9-10-20(4)25-13-14-26-22(8-7-15-28(25,26)6)11-12-23-16-24(29)17-27(30)21(23)5/h9-12,18-20,24-27,29-30H,5,7-8,13-17H2,1-4,6H3/b10-9+,22-11+,23-12-/t19-,20+,24+,25+,26-,27-,28+/m0/s1
    Key: HKXBNHCUPKIYDM-CGMHZMFXBN
  • O[C@@H]1CC(\C(=C)[C@@H](O)C1)=C\C=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@@H](/C=C/[C@H](C)C(C)C)C)C
Properties
C28H44O2
Molar mass 412.658 g·mol−1
Pharmacology
H05BX03 (WHO)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references

Doxercalciferol (or 1-hydroxyergocalciferol, trade name Hectorol) is drug for secondary hyperparathyroidism and metabolic bone disease.[1] It is a synthetic analog of ergocalciferol (vitamin D2). It suppresses parathyroid synthesis and secretion.[2]

Docercalciferol is the vitamin D2 analogue of alfacalcidol.[3] It undergoes 25-hydroxylation in the liver to become the active ercalcitriol, without the involvement of kidneys.[4]

Society and culture

Cost

The medication in the U.S. in intravenous solution 2 mcg/mL is $136 (USD) for 100 ml of Doxercalciferol [5]

  • Doxercalciferol costs (US)

    Doxercalciferol costs (US)

  • Doxercalciferol prescriptions (US)

    Doxercalciferol prescriptions (US)

References

  1. ↑ Sprague S M; Ho L T (2002). "Oral doxercalciferol therapy for secondary hyperparathyroidism in a peritoneal dialysis patient". Clinical nephrology. 58 (2): 155–160. PMID 12227689.
  2. ↑ "Doxercalciferol". Drugs.com. Archived from the original on 2020-12-05. Retrieved 2020-11-03.
  3. ↑ Upton, R. A.; Knutson, J. C.; Bishop, C. W.; LeVan, L. W. (1 April 2003). "Pharmacokinetics of doxercalciferol, a new vitamin D analogue that lowers parathyroid hormone". Nephrology Dialysis Transplantation. 18 (4): 750–758. doi:10.1093/ndt/gfg030.
  4. ↑ "HECTOROL INJECTION (doxercalciferol)" (PDF). FDA accessdata. Archived (PDF) from the original on 27 February 2017. Retrieved 21 April 2018.
  5. ↑ "Doxercalciferol Prices, Coupons & Patient Assistance Programs". Drugs.com. Archived from the original on 15 August 2019. Retrieved 28 March 2021.



Stub icon

This hormonal preparation article is a stub. You can help MDWiki by expanding it.

Retrieved from "https://mdwiki.org/w/index.php?title=Doxercalciferol&oldid=1438850"